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pound this public health problem, general practitioners (GPs) may play a major role 
to fill this treatment gap. Methods: A cross-sectional survey of 220 GPs was under-
taken in Chandigarh City, India. The 20-item Depression Attitude Questionnaire 
(DAQ) was used to determine their knowledge, attitude and practice towards depres-
sion and its management in primary care settings. Results: GPs had a limited 
knowledge of depression, with the majority (77.8%) expressing difficulty working 
with depressed patients. They exhibited moderately stigmatizing attitudes towards 
individuals with depression. GPs were conservative in their use of antidepressants 
and believed that psychotherapeutic approaches were useful. ConClusions: 
These findings suggest a need for further education of general practitioners on the 
nature, diagnosis and management of depressive disorders.
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objeCtives: To develop a population-based decision-analytic model to sup-
port decision-making with end-of-life care policy questions. Methods: Design: 
Microsimulation state-transition model with one-day cycle. Population: Patients and 
their family Outcomes: Dying at home, resources used, costs, and quality-adjusted 
survival. Perspectives: Societal and health system. Time horizon: last year of life and 
1-year bereavement. Costs: health system, out-of-pocket, and costs of time loss 
from paid-work. Effects: health-related quality of life (HRQOL, including valuation 
of leisure time) and quality-adjusted life days. Model structure – Stratified by end-of-
life trajectory (below) and risk of dying, simulated individuals might receive cura-
tive, palliative or hospice care (including combined care) at home (including “home 
care”), long-term care homes, ERs, hospitals (including ICU), complex-continuing-
care facilities, palliative care wards, or non-home hospices. Input data sources –a 
cohort study using linked Ontario health administrative databases and literature 
for HRQOL estimates associated with trajectory (e.g., cancer) and interventions 
(e.g. reduced hospital and ICU days). Model validation –Modeled projections were 
calibrated to observed data to ensure consistency. Results: The study cohort strati-
fied 256,284 Ontarians who died between Jan-2007 and Dec-2009 into: sudden death 
(4%), frailty (30%), terminal illnesses (31%), and organ failure (31%). Over the time 
horizon, approximately 60% of the simulated patients were at home with primary/
community/home care support, and 75% spent ≥ 1 day in hospitals, costing the 
health system on average approximately $31,000 (or in aggregation, approximately 
6% of the annual health care budget). Simulated patients died at home (22%), long-
term-care homes (18%), in ERs (6%), hospitals (47%), and complex-continuing-care 
facilities (7%). ConClusions: Upon further validation, our model can be used to 
evaluate the cost-effectiveness of broad integrated palliative care approaches from 
a proposed national framework, and specific evidence-based interventions (related 
to communication/decision-making, care models, determinants of place of dying, 
education, and life-sustaining care) identified through systematic reviews con-
ducted by Health Quality Ontario.
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objeCtives: DVT can lead to significant co-morbidity with post-thrombotic syn-
drome, and has the potential to cause life threatening pulmonary emboli. The 
national institute for clinical excellence (NICE) implemented stringent guidelines 
to improve screening for DVT and optimise management (NICE 2012). The Royal 
London Hospital was the designated teaching hospital receiving attending public, 
foreign dignitaries and athletes during the 2012 Olympics. We conducted a pro-
spective audit to assess incidence of DVT in a mobile population during the 2012 
Olympics, and assess adherence to NICE guidelines. Methods: Patients present-
ing with symptoms of DVT over 7 weeks during the 2012 Olympics were seen by a 
senior nurse. A clinical proforma identifying risk factors was employed. D-dimer 
and USS results were obtained from clinical reporting systems. Analysis undertaken 
on excel. Results: 69 patients with a suspected DVT underwent investigations. 
Only six patients had a DVT on Doppler USS. One DVT was deemed unprovoked 
in a young patient with upper limb DVT. In this patient CT abdomen/pelvis was 
not warranted, though tested for antiphospholipid syndrome, serum calcium was 
not measured. In the D-dimer positive scan negative cohort, a repeat USS Doppler 
at 6-8 days was not undertaken in 71% of patients. However, the initial scan was 
undertaken within 24hrs (86%). D-dimer has low sensitivity for DVT diagnosis (14%), 
but high specificity (100%) albeit within limited sample size. Further, utilising risk 
factors (Wells score) alone had a better sensitivity (28%). ConClusions: We note 
a low incidence of DVT in this young mobile population, in comparison to the gen-
eral population. A repeat Doppler USS 6-8days after presentation, when D-dimer 
was positive, is not adhered to; however none performed were positive (9). We are 
uncertain if this approach would add to a reduction in morbidity/mortality (BMJ 
2012). The D-dimer is not a sensitive marker of DVT, and risk stratification through 
identification of risk factors appears more sensitive.
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COPD and bacterial pneumonia. We used chi-square tests and logistic regressions to 
assess the unadjusted and adjusted relationships between depression and presence 
of ACSH. Results: Among all Medicare beneficiaries, 10% had diagnosed depres-
sion; “any ACSH” was reported in 5% of all elderly 25% of hospitalized elderly. “Any 
ACSH” was higher in Medicare beneficiaries with depression (11.4%) as compared to 
those without depression (4.5%). Among hospitalized elderly, 28% with depression 
and 24% without depression had “any ACSH”. Among all elderly, those with depres-
sion had two times the risk of experiencing “any ACSH” (Adjusted Odds Ratio(AOR): 
2.19; 95% Confidence Interval(CI): 1.97, 2.43) compared to those without depression. 
We observed similar findings for “chronic ACSH” (AOR: 2.44; 95% CI: 2.10, 2.84), “acute 
ACSH” and (AOR:1.98; 95%CI: 1.75, 2.25). ConClusions: Our study results indicated 
that Medicare beneficiaries with chronic physical conditions and depression were at 
risk for ACSHs. Elderly with depression chronic conditions may need to be routinely 
screened for depression. Future research needs to examine whether treating depres-
sion can reduce the risk of ACSH among elderly with depression.
PHS157
ASSeSSMent of SPiroMetry teSting AnD inPAtient reADMiSSion in 
PAtientS witH CHroniC oBStruCtive PulMonAry DiSeASe
Yu Y.1, Meyers J.2, Kaila S.1, Dhamane A1, Candrilli S.D.2
1Boehringer-Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA, 2RTI Health Solutions, Research 
Triangle Park, NC, USA
objeCtives: To assess spirometry testing and chronic obstructive pulmonary dis-
ease (COPD)-related inpatient readmission rates among managed care patients 
in the US. Methods: This retrospective administrative claims database analysis 
included patients with COPD (≥ 1 inpatient or emergency room claim or ≥ 2 outpa-
tient claims with a COPD diagnosis [ICD-9-CM diagnosis codes 491.xx, 492.xx, 494.
xx, or 496.xx]), ≥ 1 month health plan enrollment in 2011 and aged ≥ 40 years. Two 
cohorts were formed: 1) ‘Spirometry’ cohort: Patients with 24 months of enroll-
ment before and 6 months after their initial COPD diagnosis and 2) ‘Readmissions’ 
cohort: Patients with a COPD-related hospitalization (hospitalization with a primary 
diagnosis of COPD) and ≥ 1 month enrollment post-discharge). The proportion of 
patients with evidence of spirometry testing (≥ 1 claim with a CPT-4 procedure code: 
94010, 94060, 95070, 94070, 94150, 94200, 94375, or 94664) within 24 months pre- and 
6 months post-initial COPD diagnosis was assessed in the ‘Spirometry’ cohort. The 
proportion of patients with a COPD-related inpatient readmission within 30 days 
post-discharge (30-day readmission) was assessed in the ‘Readmissions’ cohort. 
Results were reported at the national, regional, and state levels. Results: A total 
of 94,778 patients were included in the ‘Spirometry’ cohort, with 37.6% having evi-
dence of spirometry testing (Northeast: 40.3%; South: 37.4%; Midwest: 37.7%; West: 
31.6%). Spirometry testing rates varied from 24.6% in Wyoming to 61.2% in Rhode 
Island. A total of 49,986 patients were included in the ‘Readmissions’ cohort, with 
7.1% having a 30-day readmission (Northeast: 7.9%; South: 6.3%; Midwest: 7.4%; 
West: 7.1%). Thirty-day readmission rates varied from 2.0% in South Dakota to 20.8% 
in Washington, DC. ConClusions: A large proportion of patients with a COPD 
diagnosis did not have evidence of spirometry testing to confirm COPD diagnosis. 
COPD-related 30-day readmissions may be of concern as well. There is a substantial 
variation in these rates across US states.
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objeCtives: Medication-related errors account for many deaths annually, and there 
is increasing evidence that these errors frequently occur upon hospital admission 
and discharge. A pharmacist-conducted pilot program was designed to provide 
medication reconciliation services to high-risk patients shortly after hospital dis-
charge to decrease medication-related errors. The primary objective is to evaluate 
the impact of a post-discharge quality improvement medication reconciliation ser-
vice. Methods: An algorithm was developed to identify patients at high-risk for 
readmission following hospital discharge. High-risk patients were defined as any 
member recently discharged from the hospital who was: a) receiving a high alert 
medication (e.g., warfarin); and/or b) was hospitalized for at least one pre-speci-
fied condition (e.g., Diabetes Mellitus). Within 2-5 days of hospital discharge, the 
Concurrent Review Nurses from a local health plan identified the high risk patients 
using the algorithm and notified the pharmacist. The pharmacist contacted the 
patients via phone to complete a medication reconciliation and clinical review with 
either the patient or their caregiver Results: The program lasted from July 2013 to 
October 2013. In total, 125 patients were identified as high-risk patients, 47 of whom 
completed a clinical consult with the pharmacist. The average age of the patients 
who participated in the service was 66. The use of high-risk meds included warfarin 
(21%), antiplatelets (34%), digoxin (13%), and insulin (28%). In total, 5 patients in this 
group (11%) were re-hospitalized within 30 days. ConClusions: In the future, this 
pilot program should be conducted on a larger scale and include patients who are 
followed for a longer period of time. Anecdotal evidence suggested that the service 
was useful, however a larger number of patients is needed to achieve sufficient 
power to detect a statistical difference.
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objeCtives: Depression is a leading cause of morbidity and disability worldwide. 
The population in developing countries is at greater risk. Inadequate trained men-
tal health staff, and unfortunately, low case detection has been associated with 
increased morbidity among subjects presenting to primary care. In order to com-
